UBS Group’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Sell |
41,523
-110,065
| -73% | -$460K | ﹤0.01% | 5567 |
|
|
2025
Q1 | $241K | Buy |
151,588
+92,012
| +154% | +$146K | ﹤0.01% | 5186 |
|
|
2024
Q4 | $169K | Buy |
59,576
+33,619
| +130% | +$95.1K | ﹤0.01% | 5356 |
|
|
2024
Q3 | $101K | Buy |
25,957
+20,707
| +394% | +$81K | ﹤0.01% | 5168 |
|
|
2024
Q2 | $42.1K | Buy |
+5,250
| New | +$42.1K | ﹤0.01% | 5681 |
|